Compare GHG & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
Current Price
| Metric | GHG | EDAP |
|---|---|---|
| Founded | 2004 | 1979 |
| Country | China | France |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.6M | 137.6M |
| IPO Year | 2018 | 1997 |
| Metric | GHG | EDAP |
|---|---|---|
| Price | $1.40 | $4.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 32.8K | ★ 93.4K |
| Earning Date | 03-30-2026 | 03-26-2026 |
| Dividend Yield | ★ 7.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $166,761,937.00 | $74,853,925.00 |
| Revenue This Year | $19.02 | N/A |
| Revenue Next Year | $8.26 | $7.15 |
| P/E Ratio | $5.60 | ★ N/A |
| Revenue Growth | N/A | ★ 0.61 |
| 52 Week Low | $1.39 | $1.21 |
| 52 Week High | $3.25 | $5.05 |
| Indicator | GHG | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 37.02 | 62.96 |
| Support Level | $1.41 | $4.17 |
| Resistance Level | $1.51 | $5.05 |
| Average True Range (ATR) | 0.04 | 0.39 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 22.17 | 76.72 |
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.